tvb-2640
Showing 1 - 7 of 7
Colon Cancer Trial in Lexington (TVB-2640, Placebo)
Recruiting
- Colon Cancer
- TVB-2640
- Placebo
-
Lexington, KentuckyUniversity of Kentucky
Jan 18, 2023
Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- TVB-2640
- Enzalutamide
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023
KRAS Gene Mutation Trial in Cincinnati, Dallas (TVB-2640)
Recruiting
- KRAS Gene Mutation
- TVB-2640
-
Cincinnati, Ohio
- +1 more
Dec 19, 2022
Non-Alcoholic Fatty Liver Disease Trial in China, United States (TVB-2640, Placebo)
Completed
- Non-Alcoholic Fatty Liver Disease
- TVB-2640
- Placebo
-
Chula Vista, California
- +22 more
Oct 27, 2021
Healthy Trial in Changsha (TVB-2640, Placebo)
Completed
- Healthy
- TVB-2640
- Placebo
-
Changsha, Hunan, ChinaHunan provincial people's hospital
Jul 3, 2020
Astrocytoma Trial in San Antonio (Bevacizumab, TVB-2640)
Active, not recruiting
- Astrocytoma
- Bevacizumab
- TVB-2640
-
San Antonio, TexasUniversity of Texas Health Science Center San Antonio at the Can
Apr 27, 2020
Solid Malignant Tumor Trial in United Kingdom, United States (TVB-2640)
Completed
- Solid Malignant Tumor
- TVB-2640
-
Scottsdale, Arizona
- +10 more
Aug 11, 2017